
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Envigo, a provider of non-clinical contract research services and research models, announced PATHWAY-an integrated solution for non-clinical safety assessment programs to enable first-in-human clinical trials. It is meant to manage the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers.
Read the full release






